Correlation Between Basilea Pharmaceutica and Straumann Holding

Can any of the company-specific risk be diversified away by investing in both Basilea Pharmaceutica and Straumann Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Basilea Pharmaceutica and Straumann Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Basilea Pharmaceutica AG and Straumann Holding AG, you can compare the effects of market volatilities on Basilea Pharmaceutica and Straumann Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Basilea Pharmaceutica with a short position of Straumann Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of Basilea Pharmaceutica and Straumann Holding.

Diversification Opportunities for Basilea Pharmaceutica and Straumann Holding

0.87

Correlation Coefficient

Basilea Pharmaceutica  Straumann Holding

Very poor diversification

The 3 months correlation between Basilea and Straumann is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Basilea Pharmaceutica AG and Straumann Holding AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Straumann Holding and Basilea Pharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Basilea Pharmaceutica AG are associated (or correlated) with Straumann Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Straumann Holding has no effect on the direction of Basilea Pharmaceutica i.e., Basilea Pharmaceutica and Straumann Holding go up and down completely randomly.

Pair Corralation between Basilea Pharmaceutica and Straumann Holding

Assuming the 90 days trading horizon Basilea Pharmaceutica AG is expected to generate 1.2 times more return on investment than Straumann Holding. However, Basilea Pharmaceutica is 1.2 times more volatile than Straumann Holding AG. It trades about 0.18 of its potential returns per unit of risk. Straumann Holding AG is currently generating about -0.01 per unit of risk. If you would invest  4,120  in Basilea Pharmaceutica AG on October 11, 2024 and sell it today you would earn a total of  195.00  from holding Basilea Pharmaceutica AG or generate 4.73% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Basilea Pharmaceutica AG  vs.  Straumann Holding AG

Basilea Pharmaceutica

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Basilea Pharmaceutica AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Basilea Pharmaceutica is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Straumann Holding

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Straumann Holding AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Pair Trading with Basilea Pharmaceutica and Straumann Holding

The main advantage of trading using opposite Basilea Pharmaceutica and Straumann Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Basilea Pharmaceutica position performs unexpectedly, Straumann Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Straumann Holding will offset losses from the drop in Straumann Holding's long position.

The idea behind Basilea Pharmaceutica AG and Straumann Holding AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.